Early clinical studies with lapachol (NSC-11905).
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy; D009285:Naphthoquinones / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D010936:Plant Extracts; D013997:Time Factors
D000970:Antineoplastic Agents; D009285:Naphthoquinones; D010936:Plant Extracts